Cart
sales@molnova.com
Deferasirox
CAS No. 201530-41-8
Deferasirox ( ICL670A )
Catalog No. M13141 CAS No. 201530-41-8
An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 71 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 156 | In Stock |
|
| 500MG | 386 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDeferasirox
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
-
DescriptionAn oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
-
SynonymsICL670A
-
PathwayOthers
-
TargetOther Targets
-
Recptoriron
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number201530-41-8
-
Formula Weight373.36
-
Molecular FormulaC21H15N3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)C1=CC=C(N2N=C(C3=CC=CC=C3O)N=C2C4=CC=CC=C4O)C=C1
-
Chemical NameBenzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sobbe A, et al. J Gastroenterol Hepatol. 2015 Mar;30(3):638-45.
2. Kim JL, et al. Acta Haematol. 2011;126(4):241-5.
3. Lee DH, et al. Exp Hematol. 2013 Jun;41(6):539-46.
2. Kim JL, et al. Acta Haematol. 2011;126(4):241-5.
3. Lee DH, et al. Exp Hematol. 2013 Jun;41(6):539-46.
molnova catalog
related products
-
Cinaciguat
Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.
-
Taurolidine
Taurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
-
(S/R)-Orteronel
TAK-700 (Orteronel) is a potent and highly selective human 17, 20-lyase inhibitor with IC50 of 38 nM, exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3.
